586
Views
4
CrossRef citations to date
0
Altmetric
Articles

Virtual screening of potential inhibitor against breast cancer-causing estrogen receptor alpha (ERα): molecular docking and dynamic simulations

, , , , , , & show all
Pages 1163-1174 | Received 25 Dec 2021, Accepted 21 Apr 2022, Published online: 14 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Le Fu, Linan Zhao, Meichen Liang, Kun Ran, Jing Fu, Haoyu Qiu, Fei Li & Mao Shu. (2023) Identification of potential CAMKK2 inhibitors based on virtual screening and molecular dynamics simulation. Molecular Simulation 49:1, pages 27-35.
Read now

Articles from other publishers (3)

Satish Anandan, Hittanahallikoppal Gajendramurthy Gowtham, C. S. Shivakumara, Anjana Thampy, Sudarshana Brijesh Singh, Mahadevamurthy Murali, Chandan Shivamallu, Sushma Pradeep, Natarajamurthy Shilpa, Ali A. Shati, Mohammad Y. Alfaifi, Serag Eldin I. Elbehairi, Joaquín Ortega-Castro, Juan Frau, Norma Flores-Holguín, Shiva Prasad Kollur & Daniel Glossman-Mitnik. (2022) Integrated approach for studying bioactive compounds from Cladosporium spp. against estrogen receptor alpha as breast cancer drug target. Scientific Reports 12:1.
Crossref
Indeewarie H. Dissanayake, Upeka Bandaranayake, Lakshika R. Keerthirathna, Chamalika. Manawadu, Rajitha M. Silva, Boudjelal Mohamed, Rizwan Ali & Dinithi C. Peiris. (2022) Integration of in vitro and in-silico analysis of Caulerpa racemosa against antioxidant, antidiabetic, and anticancer activities. Scientific Reports 12:1.
Crossref
Bilal Ahmad Khan, Muhammad Ashfaq, Shabbir Muhammad, Khurram Shahzad Munawar, Muhammad Nawaz Tahir, Abdullah G. Al-Sehemi & Saleh S. Alarfaji. (2022) Exploring Highly Functionalized Tetrahydropyridine as a Dual Inhibitor of Monoamine Oxidase A and B: Synthesis, Structural Analysis, Single Crystal XRD, Supramolecular Assembly Exploration by Hirshfeld Surface Analysis, and Computational Studies. ACS Omega 7:33, pages 29452-29464.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.